Nom du produit:tert-butyl (3-(5-oxo-1,4-oxazepan-4-yl)propyl)carbamate
IUPAC Name:tert-butyl N-[3-(5-oxo-1,4-oxazepan-4-yl)propyl]carbamate
- CAS：2542345-19-5
- Formule moléculaire：C13H24N2O4
- Pureté：95%+
- Numéro de catalogue：CM1077562
- Poids moléculaire：272.35
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2542345-19-5
- Formule moléculaire:C13H24N2O4
- Point de fusion:-
- Code SMILES:O=C(OC(C)(C)C)NCCCN1C(=O)CCOCC1
- Densité:1.081±0.06 g/cm3
- Numéro de catalogue:CM1077562
- Poids moléculaire:272.35
- Point d'ébullition:452.6±40.0 °C
- N° Mdl:
- Stockage:
Category Infos
- Azepanes
- The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.
Column Infos
- DCC-3116
- DCC-3116 is an investigational, orally administered, potent, and highly selective switch-control inhibitor of the ULK kinase. DCC-3116 is designed to inhibit autophagy, a key tumor survival mechanism in cancer cells, by inhibiting the ULK1/2 kinases, which have been shown to be the initiating factors that activate autophagy. DCC-3116 in combination with RAS/MAP kinase signaling pathway inhibition has the potential to change the treatment of RAS/RAF cancers.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
